Bioprocessing of New Medicines

Bioprocessing of new medicines sits at the frontier of pharmaceutical development, focusing on the biological and engineering processes by which modern therapies, including vaccines, monoclonal antibodies, cell and gene therapies, and other biological medicines, are designed, produced, and scaled up for manufacture. It is a highly applied science that bridges biology, chemistry, and engineering, and it is one of the fastest-growing areas in healthcare. This variant of the programme at UCL includes a significant component in business and management, recognising that the pharmaceutical and biotech industries require people who can navigate commercial strategy, regulatory environments, and organisational leadership as well as understanding the science.

At University College London, this three-year degree develops your scientific grounding in the biological principles underlying drug development, including cell biology, biochemistry, and microbiology, alongside the engineering and process design knowledge needed to produce medicines at scale. The business and management strand introduces you to the commercial, strategic, and operational dimensions of the pharmaceutical industry, covering areas such as project management, regulatory affairs, and the economics of drug development. UCL's connections to the life sciences sector in London provide exceptional access to the research, industry, and clinical communities that define this field.

Graduates from this programme are well positioned to enter the rapidly expanding biotechnology and pharmaceutical sectors in roles that require both scientific credibility and commercial awareness. Process development, manufacturing, quality assurance, and regulatory roles within biotech companies, contract manufacturing organisations, and large pharmaceutical firms are direct career pathways. The management component also opens doors into project management, business development, and consultancy within the life sciences sector.

Many graduates continue to postgraduate study or professional qualifications in areas such as pharmaceutical science, regulatory affairs, or business administration, deepening their expertise in preparation for senior roles.